Metabolism of estradiol-17β, 5-androstene-3β,17β-diol and testosterone in human breast cancer cells in long-term culture
Publication date
1980-07
Authors
Rademaker, B.
Vossenberg, J.B.J.
Poortman, J.
Thijssen, J.H.H.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
The human breast cancer cell line MCF-7 is able to metabolize steroids, which are added in order to study the growth rate of these cells. The following steroids: estradiol-17β, 5-androstene-3β,17β-diol and testosterone were incubated with these cells for 48 h under identical conditions used for growth-rate studies in our laboratory. The metabolites formed were identified. The conversion of estradiol-17β to estrone was 7% and no estriol was formed. The conversion of 5-androstene-3β-17β-diol to dehydroepiandrosterone was 8.1%, to testosterone 1.0% and to 5α-androstane-3β,17β-diol 3.2%. The conversion of testosterone to androstenedione was 6.5%, to etiocholanolone 0.4%, to 5α-dihydrotestosterone 0.7%, to 5-androstene-3β,17β-diol 0.5% and to androstenediol 0.2%. Some of these metabolites, due to their relative binding affinity, may have a biological effect on these cells that contain androgen and estrogen receptors.